Mediwelcome Healthcare Management & Technology Inc.

SEHK:2159 Stock Report

Market Cap: HK$97.0m

Mediwelcome Healthcare Management & Technology Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Liang Wang

Chief executive officer

CN¥691.0k

Total compensation

CEO salary percentage86.8%
CEO tenure5.4yrs
CEO ownership6.0%
Management average tenure5.4yrs
Board average tenure4.8yrs

Recent management updates

Recent updates

Mediwelcome Healthcare Management & Technology Inc. (HKG:2159) Stock Catapults 41% Though Its Price And Business Still Lag The Industry

Dec 17
Mediwelcome Healthcare Management & Technology Inc. (HKG:2159) Stock Catapults 41% Though Its Price And Business Still Lag The Industry

There's No Escaping Mediwelcome Healthcare Management & Technology Inc.'s (HKG:2159) Muted Revenues Despite A 25% Share Price Rise

Oct 03
There's No Escaping Mediwelcome Healthcare Management & Technology Inc.'s (HKG:2159) Muted Revenues Despite A 25% Share Price Rise

Mediwelcome Healthcare Management & Technology Inc. (HKG:2159) Surges 28% Yet Its Low P/S Is No Reason For Excitement

Jun 18
Mediwelcome Healthcare Management & Technology Inc. (HKG:2159) Surges 28% Yet Its Low P/S Is No Reason For Excitement

Improved Revenues Required Before Mediwelcome Healthcare Management & Technology Inc. (HKG:2159) Shares Find Their Feet

Mar 06
Improved Revenues Required Before Mediwelcome Healthcare Management & Technology Inc. (HKG:2159) Shares Find Their Feet

There's No Escaping Mediwelcome Healthcare Management & Technology Inc.'s (HKG:2159) Muted Revenues

Aug 15
There's No Escaping Mediwelcome Healthcare Management & Technology Inc.'s (HKG:2159) Muted Revenues

Mediwelcome Healthcare Management & Technology (HKG:2159) Might Be Having Difficulty Using Its Capital Effectively

Aug 12
Mediwelcome Healthcare Management & Technology (HKG:2159) Might Be Having Difficulty Using Its Capital Effectively

Calculating The Intrinsic Value Of Mediwelcome Healthcare Management & Technology Inc. (HKG:2159)

Apr 08
Calculating The Intrinsic Value Of Mediwelcome Healthcare Management & Technology Inc. (HKG:2159)

Some Investors May Be Worried About Mediwelcome Healthcare Management & Technology's (HKG:2159) Returns On Capital

Jan 24
Some Investors May Be Worried About Mediwelcome Healthcare Management & Technology's (HKG:2159) Returns On Capital

CEO Compensation Analysis

How has Liang Wang's remuneration changed compared to Mediwelcome Healthcare Management & Technology's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-CN¥81m

Mar 31 2024n/an/a

-CN¥87m

Dec 31 2023CN¥691kCN¥600k

-CN¥94m

Sep 30 2023n/an/a

-CN¥86m

Jun 30 2023n/an/a

-CN¥79m

Mar 31 2023n/an/a

-CN¥84m

Dec 31 2022CN¥2mCN¥570k

-CN¥89m

Sep 30 2022n/an/a

-CN¥57m

Jun 30 2022n/an/a

-CN¥26m

Mar 31 2022n/an/a

-CN¥11m

Dec 31 2021CN¥3mCN¥650k

CN¥5m

Sep 30 2021n/an/a

CN¥6m

Jun 30 2021n/an/a

CN¥8m

Mar 31 2021n/an/a

CN¥14m

Dec 31 2020CN¥662kCN¥600k

CN¥21m

Sep 30 2020n/an/a

CN¥19m

Jun 30 2020n/an/a

CN¥16m

Mar 31 2020n/an/a

CN¥18m

Dec 31 2019CN¥665kCN¥573k

CN¥21m

Compensation vs Market: Liang's total compensation ($USD94.54K) is below average for companies of similar size in the Hong Kong market ($USD229.33K).

Compensation vs Earnings: Liang's compensation has been consistent with company performance over the past year.


CEO

Liang Wang (48 yo)

5.4yrs

Tenure

CN¥691,000

Compensation

Mr. Liang Wang serves as the Chief Executive Officer at Mediwelcome Healthcare Management & Technology Inc. and has been its Executive Director since September 18, 2019. Mr. Wang co-founded Mediwelcome Gro...


Leadership Team

NamePositionTenureCompensationOwnership
Wei Shi
Executive Chairman of the Board6yrsCN¥691.00k20.33%
HK$ 19.7m
Liang Wang
CEO & Executive Directorno dataCN¥691.00k6.02%
HK$ 5.8m
Weimin Yang
Executive Vice Chairman of the Board5.4yrsCN¥691.00k12.71%
HK$ 12.3m
Guijin Liu
CFO & Executive Directorno datano datano data
Haidong Jiang
Chief Technology Officerno datano datano data
Luyang Zhao
VP of Human Resources & Joint Company Secretary5.4yrsno datano data
Siu Wai Tsoi
Joint Company Secretary3.3yrsno datano data

5.4yrs

Average Tenure

48yo

Average Age

Experienced Management: 2159's management team is seasoned and experienced (5.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Wei Shi
Executive Chairman of the Board6yrsCN¥691.00k20.33%
HK$ 19.7m
Liang Wang
CEO & Executive Director5.4yrsCN¥691.00k6.02%
HK$ 5.8m
Weimin Yang
Executive Vice Chairman of the Board5.4yrsCN¥691.00k12.71%
HK$ 12.3m
Guijin Liu
CFO & Executive Directorless than a yearno datano data
Ruilin Song
Independent Non-Executive Director4.2yrsCN¥321.00kno data
Zheng Wang
Independent Non-Executive Director4.2yrsCN¥229.00kno data
Xiaoxi Yang
Independent Non-Executive Director4.2yrsCN¥227.00kno data
Xia Liu
Non-Executive Director5.4yrsno datano data

4.8yrs

Average Tenure

48yo

Average Age

Experienced Board: 2159's board of directors are considered experienced (4.8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/12 02:18
End of Day Share Price 2025/02/12 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Mediwelcome Healthcare Management & Technology Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.